Pasar al contenido principal

NUEVAS HERRAMIENTAS PARA EL DESCUBRIMIENTO DE FARMACOS Y LA DETECCION DE RESISTENCIAS ANTIHELMINTICAS FRENTE A LAS NEMATODOSIS GASTROINTESTINALES EN PEQUEÑOS RUMIANTES

PRE2021-096909

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Desarrollar, Atraer y Retener Talento
Subprograma Subprograma Estatal de Formación
Convocatoria Contratos Predoctorales
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE LEÓN

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

New benzimidazole derivative compounds with in vitro fasciolicidal properties

  • Valderas-García, Elora
  • Castilla Gómez de Agüero, Verónica
  • González Del Palacio, Laura
  • Galli, Giulio
  • Escala, Nerea
  • Ruiz-Somacarrera, Marta
  • González-Warleta, Marta
  • Del Olmo, Esther
  • Balaña-Fouce, Rafael
  • Martínez Valladares, María
13 páginas, 2 figuras, 5 tablas., Control of the zoonotic food-borne parasite Fasciola hepatica remains a major challenge in humans and livestock. It is estimated that annual economic losses due to fasciolosis can reach US$3.2 billion in agriculture and livestock. Moreover, the wide distribution of drug-resistant parasite populations and the absence of a vaccine threaten sustainable control, reinforcing the need for novel flukicides., Financial support came from PID2020-119035RB-100 funded by MCIN/ AEI/10.13039/501100011033 and, by “ERDF A way of making Europe”. EVG was funded by European Union Next Generation EU/PRTR (Margarita Salas Grant for the training of young doctors); VCGA and LGDP are recipients of Junta de Castilla y León (JCyL) grants (LE082-18, LE096-20, respectively); GG was funded by PRE2021-096909, grant funded by MCIN/AEI/10.13039/501100011033 and, by “ESF Investing in your future”, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

In vitro and ex vivo synergistic effect of pyrvinium pamoate combined with miltefosine and paromomycin against Leishmania

  • Melcón-Fernández, Estela
  • Galli, Giulio
  • Balaña-Fouce, Rafael
  • García-Fernández, Nerea
  • Martínez Valladares, María
  • Reguera, Rosa M
  • García-Estrada, Carlos
  • Pérez-Pertejo, Yolanda
17 páginas, 11 figuras, 6 tablas., One of the major drawbacks of current treatments for neglected tropical diseases is the low safety of the drugs used and the emergence of resistance. Leishmaniasis is a group of neglected diseases caused by protozoa of the trypanosomatidae family that lacks preventive vaccines and whose pharmacological treatments are scarce and unsafe. Combination therapy is a strategy that could solve the above-mentioned problems, due to the participation of several mechanisms of action and the reduction in the amount of drug necessary to obtain the therapeutic effect. In addition, this approach also increases the odds of finding an effective drug following the repurposing strategy. From the previous screening of two collections of repositioning drugs, we found that pyrvinium pamoate had a potent leishmanicidal effect. For this reason, we decided to combine it separately with two clinically used leishmanicidal drugs, miltefosine and paromomycin. These combinations were tested in axenic amastigotes of Leishmania infantum obtained from bone marrow cells and in intramacrophagic amastigotes obtained from primary cultures of splenic cells, both cell types coming from experimentally infected mice. Some of the combinations showed synergistic behavior, especially in the case of the combination of pyrvinium pamoate with paromomycin, and exhibited low cytotoxicity and good tolerability on intestinal murine organoids, which reveal the potential of these combinations for the treatment of leishmaniasis., G.G. is supported by Grant PRE2021–096909 funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future”. N.G.-F. is supported by University of León., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

An Ovine Intestinal Organoid–Macrophage Co-Culture Model to Test the Effects of Ovine Colostrum Exosomes on Intestinal Barrier Function and Inflammation

  • Dehnavi, Mahsa
  • Galli, Giulio
  • García-Estrada, Carlos
  • Balaña-Fouce, Rafael
  • Giráldez, Francisco Javier
  • Alonso, Mercedes
  • Santos Antón, Nuria
  • Rozada, F.
  • Andrés, Sonia
This article belongs to the Special Issue Intestinal 3D Culture, Organoids and Gut-on-Chip in Intestinal Disorders, Ovine colostrum exosomes obtained from nutritionally programmed dairy ewes (F0) may present modifications in microRNAs, thus having consequences for the intestinal barrier function and immunity parameters of lambs (F1). To test this hypothesis, colostrum exosomes from two ewe groups [F0-MET (nutritionally programmed ewes being fed methionine during early life) and F0-CTRL (ewes not supplemented with methionine during early life)] were sequenced to compare differences in the miRNAome. In addition, these exosomes were added to an in vitro co-culture in a Transwell chamber system consisting of ovine duodenum intestinal organoids and macrophages to assess the expression of genes encoding tight junction proteins in organoids and immunity parameters in macrophages. Finally, the concentrations of cytokines (e.g., IL-12 and IL-6) were assessed by ELISA kits in the supernatants of the chamber containing macrophages. According to the miRNAome, the expression of two miRNAs (e.g., oar_miR_376c_3p and oar_miR_432) was reduced in the colostrum exosomes obtained from dairy ewes nutritionally programmed with dietary supplementation of methionine during early life (F0-MET ewes). These changes did not seem to modify the expression of intestinal barrier and immune response marker genes when these exosomes were added to a co-culture of ovine intestinal organoids and macrophages. However, the levels of IL-12 produced by macrophages were reduced (p < 0.05), which suggests the inhibition of inflammatory pathways. Further studies using ovine colostrum exosomes obtained from nutritionally programmed ewes will help to clarify their potential to improve the health of suckling lambs., This work was supported by grant PID2021-126489OB-I00 funded by MCIN/AEI/10.13039/501100011033, “FEDER Una manera de hacer Europa”, and by grant PID2020-119035RB-I00 funded by MICIN/AEI/10.13039/501100011033. G. Galli received grant PRE2021-096909 funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future”., Peer reviewed